CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Conditions
Epithelial Ovarian Cancer · Primary Peritoneal · Fallopian Tube Cancer · Endometrioid Ovarian Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Mayo Clinic Hospital, Phoenix, Arizona, United States
SCRI - Arizona Oncology Associates, PC-HOPE, Tucson, Arizona, United States
City of Hope National Medical Center, Duarte, California, United States
Providence St. Jude Medical Center, Fullerton, California, United States
UCLA - JCCC Clinical Research Unit, Los Angeles, California, United States
Stanford Cancer Center, Palo Alto, California, United States
SCRI - Sansum Clinic, Santa Barbara, California, United States
Smilow Cancer Hospital at Yale - New Haven, New Haven, Connecticut, United States
Mayo Clinic Florida, Jacksonville, Florida, United States
Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
University of Chicago Medical Center, Chicago, Illinois, United States
SCRI - Maryland Oncology Hematology, P.A., Annapolis, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
SCRI - Minnesota Oncology Hematology, P.A., Minneapolis, Minnesota, United States
University of Minnesota, Minneapolis, Minnesota, United States
Mayo Clinic, Rochester, Minnesota, United States
Washington University, St Louis, Missouri, United States
Rutgers Cancer Institute, New Brunswick, New Jersey, United States
Duke Cancer Center, Durham, North Carolina, United States
The James Cancer Hospital and Solove Research Institute - Ohio State University, Columbus, Ohio, United States
Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, Oklahoma, United States
SCRI - Northwest Cancer Specialists, P.C., Portland, Oregon, United States
SCRI - Alliance Cancer Specialists, PC, Doylestown, Pennsylvania, United States
Contact: Study coordinator (Principal Investigator, MD) · CATALINA-2-Study@torlbio.com · 310-348-9636University of Pennsylvania, Philadelphia, Pennsylvania, United States
SCRI - Texas Oncology, Fort Worth, Texas, United States
SCRI - Virginia Oncology Associates, Norfolk, Virginia, United States
Monash Medical Centre, Clayton, Melbourne, Australia
Blacktown Hospital, Blacktown, New South Wales, Australia
Icon Cancer Centre Chermside, Chermside, Queensland, Australia
Flinders Medical Centre, Bedford Park, South Australia, Australia
Linear Clinical Research, Perth, Western Australia, Australia
Medizinische Universitat Landeskrankenhaus Graz, Graz, Styria, Austria
Universitatsklinik Innsbruck, Innsbruck, Tyrol, Austria
Ordensklinikum Linz, Linz, Upper Austria, Austria
Antwerp University Hospital (UZA), Edegem, Antwerp, Belgium
Cliniques Universitaires Saint-Luc, Woluwe-Saint-Lambert, Brussels Capital, Belgium
UZ Leuven, Leuven, Flemish Brabant, Belgium
CHU Liège, Liège, Wallonia, Belgium
BC Cancer - Abbotsford, Abbotsford British Columbia, British Columbia, Canada
British Columbia Cancer Agency (BC Cancer, part of the Provincial Health Services Authority), Vancouver, British Columbia, Canada
Sunnybrook Research Institute, Toronto, Ontario, Canada
Princess Margaret Cancer Centre - University Health Network (UHN), Toronto, Ontario, Canada
Hospital Maisonneuve Rosemont, Montreal, Quebec, Canada
Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada
Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada
McGill University Health Centre (MUHC) - Royal Victoria Hospital, Montreal, Quebec, Canada
Centre Leon Berard, Lyon, Auvergne- Rhôn-Alpes, France
Institut de Cancérologie de l'Ouest, Saint-Herblain, Pays de la Loire Region, France
Institut Gustave Roussy, Villejuif, Île-de-France Region, France
Universitatsklinikum Heidelberg, Heidelberg, Baden-Wurttenberg, Germany
Universitätsklinikum Erlangen, Erlangen, Bavaria, Germany
Charité Universitätsmedizin Berlin, Berlin, State of Berlin, Germany
Start Dublin - Mater Misericordiae University Hospital, Dublin, Leinster, Ireland
St. James Hospital, Dublin, Leinster, Ireland
IRCCS Giovani Paolo II - Instituto Oncologico, Bari, Apulia, Italy
Humanitas San Pio X, Milan, Milano, Italy
Nuovo Ospedale di Prato S Stefano, Prato, Prato, Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Rome, Italy
National University Cancer Institute, Singapore, Singapore, Singapore
National Cancer Centre, Singapore, Singapore, Singapore
Curie Oncology (Farrer), Singapore, Singapore, Singapore
Seoul National University Hospital, Seoul, Gwanak-gu, South Korea
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Seocho-Gu, South Korea
Yonsei University Health System, Severance Hospital, Seoul, Seodaemun-Gu, South Korea
Asan Medical Center, Seoul, Songpa-Gu, South Korea
Institut Catalá d'Oncologia de Girona, Girona, Catalonia, Spain